We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

191 hedge funds and large institutions have $657M invested in Meridian Bioscience Inc in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $2.7M | Put options by funds: $1.65M

10% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 59

9% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 34

0% more funds holding

Funds holding: 191 → 191 (0)

28% less capital invested

Capital invested by funds: $915M → $657M (-$258M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
191
Holders Change
–
Holders Change %
0%
% of All Funds
3.85%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
37
Increased
65
Reduced
59
Closed
34
Calls
$2.7M
Puts
$1.65M
Net Calls
+$1.05M
Net Calls Change
-$1.76M

Top Buyers

Rank Fund Capital Flow
1
FP
Foundry Partners
Minnesota
+$5.61M
2
RA
Royce & Associates
New York
+$4.82M
3
CEI
Clark Estates Inc
New York
+$4.28M
4
Charles Schwab
Charles Schwab
California
+$3.99M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.92M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$12.9M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$5.96M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.9M
4
Renaissance Technologies
Renaissance Technologies
New York
-$5.25M
5
Invesco
Invesco
Georgia
-$3.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
201
Bogle Investment Management
Massachusetts
– -$584K -25,058 Closed
AAP
202
Ardsley Advisory Partners
Connecticut
– -$547K -23,500 Closed
LPL Financial
203
LPL Financial
California
– -$440K -18,880 Closed
SSA
204
Schonfeld Strategic Advisors
New York
– -$394K -16,909 Closed
GIA
205
Gladstone Institutional Advisory
Florida
– -$382K -16,409 Closed
Connor, Clark & Lunn Investment Management (CC&L)
206
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$363K -15,571 Closed
FRM
207
Fox Run Management
Connecticut
– -$347K -14,888 Closed
American Century Companies
208
American Century Companies
Missouri
– -$343K -14,736 Closed
PC
209
Polar Capital
United Kingdom
– -$275K -11,798 Closed
PP
210
Paloma Partners
Connecticut
– -$250K -10,722 Closed
VF
211
Virtu Financial
New York
– -$247K -10,616 Closed
QT
212
Quantamental Technologies
New York
– -$241K -10,339 Closed
CC
213
Centiva Capital
New York
– -$204K -8,753 Closed
Simplex Trading
214
Simplex Trading
Illinois
– -$141K -7,278 Closed
LIA
215
LS Investment Advisors
Michigan
– -$34K -1,440 Closed
PAG
216
Private Advisor Group
New Jersey
– -$32K -1,375 Closed
CAN
217
Cetera Advisor Networks
California
– -$28K -1,200 Closed
OIA
218
Optimum Investment Advisors
Illinois
– -$23K -1,000 Closed
Bessemer Group
219
Bessemer Group
New Jersey
– -$14K -606 Closed
CCA
220
Column Capital Advisors
Indiana
– -$7K -325 Closed
Federated Hermes
221
Federated Hermes
Pennsylvania
– -$4K -155 Closed
VFA
222
Valeo Financial Advisors
Indiana
– -$1K -26 Closed
EI
223
Ellevest Inc
New York
– +$78 +4 New
Northwestern Mutual Wealth Management
224
Northwestern Mutual Wealth Management
Wisconsin
– +$97 +5 New
5 6 7 8
9

VIVO Hedge Fund Activity: Q3 2020 in Review

191 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2020, worth a combined $657M — down 28% from $915M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VIVO positions and 34 closed out — a net gain of 3 holders — while 65 added to existing stakes and 59 trimmed.

The largest buyer was Foundry Partners, opening a new position worth an estimated $5.61M. The largest seller was Millennium Management, cutting an estimated $12.9M.

  • 191 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $657M of Meridian Bioscience Inc stock for Q3 2020, down 28% quarter-over-quarter.
  • 37 funds opened new Meridian Bioscience Inc positions in Q3 2020 and 34 closed out, a net change of +3 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2020 was Foundry Partners, an estimated $5.61M added.
  • The largest Meridian Bioscience Inc seller in Q3 2020 was Millennium Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q3 2020.